Parkside Center For Nursing And Rehab At Ellijay | |
1362 South Main Street, Ellijay, Georgia 30540 | |
(706) 635-7881 | |
Name | Parkside Center For Nursing And Rehab At Ellijay |
---|---|
Location | 1362 South Main Street, Ellijay, Georgia |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 100 |
Occupancy Rate | 83.8% |
Medicare ID (CCN) | 115683 |
Legal Business Name | Parkside Operating Company Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1861954620 |
Organization Name | PARKSIDE OPERATING COMPANY LLC |
Doing Business As | PARKSIDE CENTER FOR NURSING AND REHAB AT ELLIJAY |
Address | 1362 S Main St, Ellijay, GA 30540 |
Phone Number | 706-635-7881 |
News Archive
A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment.
BioNanomatrix, Inc., a developer of breakthrough single-molecule genomic analysis technology, today announced receipt of two new supplemental grants totaling $833,490 from the National Human Genome Research Institute (NHGRI) of the U.S. National Institutes of Health (NIH). The funding is intended to support further commercial development of BioNanomatrix's nanoscale whole genome imaging and analysis platform.
Offering a likely insight into how such cancers develop in humans - Cornell University researchers report they have identified a gene that increases the risk for colon cancer in laboratory mice when the animals' diets are deficient in folate.
QA International (QAI) announced today its Virtual Human Body App for iPad is now available from the App Store. People of all ages will enjoy fingertip navigation through the 10 systems and structures of the human body, with lifelike imagery.
Beth Israel Deaconess Medical Center has received a four-year, $20 million grant from the Bill & Melinda Gates Foundation to evaluate and test broadly neutralizing monoclonal antibodies for the treatment of HIV.
› Verified 7 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment.
BioNanomatrix, Inc., a developer of breakthrough single-molecule genomic analysis technology, today announced receipt of two new supplemental grants totaling $833,490 from the National Human Genome Research Institute (NHGRI) of the U.S. National Institutes of Health (NIH). The funding is intended to support further commercial development of BioNanomatrix's nanoscale whole genome imaging and analysis platform.
Offering a likely insight into how such cancers develop in humans - Cornell University researchers report they have identified a gene that increases the risk for colon cancer in laboratory mice when the animals' diets are deficient in folate.
QA International (QAI) announced today its Virtual Human Body App for iPad is now available from the App Store. People of all ages will enjoy fingertip navigation through the 10 systems and structures of the human body, with lifelike imagery.
Beth Israel Deaconess Medical Center has received a four-year, $20 million grant from the Bill & Melinda Gates Foundation to evaluate and test broadly neutralizing monoclonal antibodies for the treatment of HIV.
› Verified 7 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 3 |
Total Amount of Fines in Dollars | $5850 |
Number of Payment Denials | 0 |
Total Number of Penalties | 3 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 22.54 | 14.46 |
Percentage of long-stay residents who lose too much weight | 12.04 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 53.45 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.67 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.47 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 6.19 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 6.43 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.36 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 14.55 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 83.11 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 33.52 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 36.24 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 7.78 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.13 | 95.98 |
Percentage of short-stay residents who made improvements in function | 83.68 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.42 | 82.93 |
News Archive
A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment.
BioNanomatrix, Inc., a developer of breakthrough single-molecule genomic analysis technology, today announced receipt of two new supplemental grants totaling $833,490 from the National Human Genome Research Institute (NHGRI) of the U.S. National Institutes of Health (NIH). The funding is intended to support further commercial development of BioNanomatrix's nanoscale whole genome imaging and analysis platform.
Offering a likely insight into how such cancers develop in humans - Cornell University researchers report they have identified a gene that increases the risk for colon cancer in laboratory mice when the animals' diets are deficient in folate.
QA International (QAI) announced today its Virtual Human Body App for iPad is now available from the App Store. People of all ages will enjoy fingertip navigation through the 10 systems and structures of the human body, with lifelike imagery.
Beth Israel Deaconess Medical Center has received a four-year, $20 million grant from the Bill & Melinda Gates Foundation to evaluate and test broadly neutralizing monoclonal antibodies for the treatment of HIV.
› Verified 7 days ago
Parkside Center For Nursing And Rehab At Ellijay Location: 1362 South Main Street, Ellijay, Georgia 30540 Phone: (706) 635-7881 |